Advertisement
Research Article

Phase I Evaluation of Intravenous Ascorbic Acid in Combination with Gemcitabine and Erlotinib in Patients with Metastatic Pancreatic Cancer

  • Daniel A. Monti,

    Affiliation: Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Edith Mitchell,

    Affiliation: Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Anthony J. Bazzan,

    Affiliation: Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Susan Littman,

    Affiliation: Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • George Zabrecky,

    Affiliation: Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Charles J. Yeo,

    Affiliation: Department of Surgery and the Jefferson Pancreas, Biliary, and Related Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Madhaven V. Pillai,

    Affiliation: Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Andrew B. Newberg,

    Affiliation: Myrna Brind Center of Integrative Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Sandeep Deshmukh,

    Affiliation: Department of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, United States of America

    X
  • Mark Levine mail

    MarkL@mail.nih.gov

    Affiliation: Molecular and Clinical Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States of America

    X
  • Published: January 17, 2012
  • DOI: 10.1371/journal.pone.0029794

Reader Comments (1)

Post a new comment on this article

Publisher's Note: Omission in Acknowledgements.

Posted by PLoS_ONE_Group on 31 Jul 2012 at 23:33 GMT

Preclinical
http://plosone.org/article/info:doi/10.1371/journal.pone.0029794#article1.front1.article-meta1.abstract1.sec1.p1

An individual was omitted from the Acknowledgements. The correct statement should read: We acknowledge Michael Mathews and Joel Edman for their assistance with research coordination.

No competing interests declared.